Interferon beta therapy for multiple sclerosis

Lancet. 1998 Nov 7;352(9139):1486-7. doi: 10.1016/S0140-6736(98)00057-9.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Comment
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Europe
  • Humans
  • Interferon beta-1a
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis / therapy*

Substances

  • Interferon-beta
  • Interferon beta-1a